Peplin Announces the Initiation of Phase 3 Clinical Trials for PEP005 Gel in AK on the Face and Scalp read more
Peplin's Successful Phase II AK Trial Results Published in JAAD read more
Positive Results for Peplin's First Phase III AK Trial read more
For more detailed stock information click Here.
Convert chart to Excel
Sign up for email alerts
The stock information provided is for informational purposes only and is not intended for trading purposes. The stock information is provided by eSignal, stock charts are provided by EDGAR Online, both third party services, and Peplin does not maintain or provide information directly to this service. Stock information is delayed approximately 20 minutes.
Latest Corporate Presentation
March 31, 2009 8K
February PEPTalk
Subscribe to our email list to be alerted by email to any company releases. A confirmatory email will be sent to you when you subscribe.
click here to sign up for Email Alerts